These results implied that the upregulation of Fas expression on tumor cells by irradiation could improve their lytic susceptibility to antigen-specific T-lymphocytes, which may be one of potential mechanisms underlying the synergistic antitumor activity of adoptive T cell therapy and radiotherapy. The gene discussed is FAS; the disease is neoplasm.